View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AC21 | Publication ID: Spring 2002 |
Title: Chronic Wasting Disease: Control of Food Products and Cosmetics Derived From Exposed Animal Populations | |
Abstract: The Food and Drug Administration (FDA) is proposing to prohibit the use of cervids (deer, elk) for food, including dietary supplements, and cosmetics if the cervids have been exposed to chronic wasting disease (CWD). FDA is proposing this regulation because of potential risks to health. CWD is a type of transmissible spongiform encephalopathy (TSE), a group of fatal, neurodegenerative diseases that include bovine spongiform encephalopathy (BSE) in cattle, scrapie in sheep, and Creutzfeldt-Jakob disease (CJD) in humans. CWD affects cervids in the United States and Canada. CWD is endemic in cervid populations in certain areas of Colorado, Nebraska, and Wyoming. The disease has been identified in wild and farmed elk and wild deer populations. At least one published scientific article has reported that infectious CWD prion proteins in vitro can convert normal, non-infectious human prion proteins into abnormal, infectious forms. These data suggest that the agent of CWD could be transmitted to humans. Currently, there are no validated analytical tests to identify animals in the pre-clinical phase of CWD, or any other TSE. CWD typically exhibits a long incubation period, during which time animals appear normal but are likely to be infectious. Therefore, FDA is proposing to require that food or cosmetic products derived from animals exposed to CWD not enter into commerce. | |
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: Not Yet Determined (To search for a specific CFR, visit the Code of Federal Regulations.) | |
Legal Authority: 42 USC 264 21 USC 301 et seq |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Yes | Government Levels Affected: Undetermined |
Small Entities Affected: Businesses | Federalism: Undetermined |
Included in the Regulatory Plan: No | |
Agency Contact: Rebecca Buckner Consumer Safety Officer Department of Health and Human Services Food and Drug Administration HFS-306, Center for Food Safety and Applied Nutrition (HFS-316), 5100 Paint Branch Parkway, College Park, MD 20740 Phone:301 436-1486 Fax:301 436-2632 Email: rebecca.buckner@fda.hhs.gov |